Bayer Aktiengesellschaft (ETR:BAYN) Trading 2.6% Higher – Still a Buy?

Shares of Bayer Aktiengesellschaft (ETR:BAYN) traded up 2.6% during mid-day trading on Thursday . The stock traded as high as €40.37 and last traded at €39.59. Approximately 3,571,930 shares changed hands during mid-day trading, The stock had previously closed at €38.60.

Bayer Aktiengesellschaft Stock Performance

The company has a 50 day simple moving average of €37.91 and a 200 day simple moving average of €39.47. The company has a market capitalization of $47.45 billion, a PE ratio of -53.92, a price-to-earnings-growth ratio of 36.39 and a beta of 0.84. The company has a debt-to-equity ratio of 134.81, a quick ratio of 0.72 and a current ratio of 1.06.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.